North America Next-Generation Antibody Therapeutics Market Is Expected to Witness the Fastest Growth

Free Press Release DB | Press Release Date : Nov 14, 2017  Download

Next-Generation Antibody Therapeutics Market -Global Opportunity Analysis, Regional Outlook,Top Key Players and Industry Forecast 2015 – 2020

Global next-generation antibody therapeutics market is growing due to increasing popularity of antibody-drug conjugate (ADC) and increasing number of collaborations for R&D in next-generation antibody therapeutics. In addition, growing prevalence of chronic diseases and increase in research and development investments by various organizations for production of improved products further encourages the growth of global next-generation antibody therapeutics market. Furthermore, increase in healthcare expenditure and technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, which is resulting in increased demand for next-generation antibody therapeutics. 

Governments of various countries are involved in taking initiatives for improving healthcare facilities, and making next-generation antibody therapeutics affordable. This is increasing the demand for next-generation antibody therapeutics. The increasing global gross domestic product (GDP) and growing healthcare expenditure have created a positive impact on the growth of the next-generation antibody therapeutics market. Also, in comparison to traditional antibodies, the next-generation antibody therapeutics is more effective in the treatment of various diseases, such as cancer, autoimmune disorders, and inflammatory diseases. This is attracting various pharmaceutical and biotechnology companies to increase their investment in the R&D of next-generation antibody therapeutics. 

 Download Free Sample of This Research Report: 

The key companies operating in the global next-generation antibody therapeutics market include Seattle Genetics Inc., F. Hoffmann-La Roche Ltd, ImmunoGen Inc., Pfizer Inc., Amgen Inc., Biogen, Kyowa Hakko Kirin Co. Ltd., Bristol-Myers Squibb Company, Xencor Inc., AstraZeneca PLC., Dyax Corp., Takeda Pharmaceuticals Company Limited and Bayer AG. 

Make Enquiry Before Buying this Report: 

Mr. Kundan Kumar

Manager – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +18887787886 (USA/Canada)



Connect with us: LinkedIn | Twitter | Google + | Facebook


Contact Person & Company



Vin Smith



Contact Numbers

Telephone No.


Fax No.


Handphone No.



Website 1


Website 2




PR Tags


Next-generation Antibody Therapeutics Market,


Contact The Author

Contact Vin Smith

More Press Release From Author

Transdermal Drug Delivery Systems Market Share Analysis of The Top Key Players, Growth Opportunities and Country Level Segments

Free Press Release DB :

Transdermal drug delivery systems market is forecasted to cross $60 billion in size by 2023, according to P&S Market Research. --> Read This Press Release !

By : Vin, Smith ( Mar 5, 2018 )
Category : Healthcare Press Release | Country : United States Press Release

Ultrasound Device Market Geographical Opportunities, Share & Growth Analysis Forcast to 2022

Free Press Release DB :

The global ultrasound device market was valued at $6,014.4 million in 2015, and it is expected to grow at a CAGR of 5.5% during 2016-2022. --> Read This Press Release !

By : Vin, Smith ( Feb 22, 2018 )
Category : Business Press Release | Country : United States Press Release

Peripheral I.V. Catheter Market Comprehensive Review of its Applications Growth Opportunities

Free Press Release DB :

Global Peripheral I.V. Catheter Market Industry Insights by Type, Technology, Clinical Area, End User- Size, Share, Development, Growth and Demand . --> Read This Press Release !

By : Vin, Smith ( Feb 20, 2018 )
Category : News Press Release | Country : United States Press Release

Read More Articles From Vin Smith


The author of the press releases are solely responsible for the content of their press releases. can't be held liable for the content posted by author. Please check the accuracy of the press release before using the press release. If necessary please contact the author. Thank you.

Report Abuse